REGAIN: a randomized controlled clinical trial of oxaloacetate for improving the symptoms of long COVID.
Saved in:
| Title: | REGAIN: a randomized controlled clinical trial of oxaloacetate for improving the symptoms of long COVID. |
|---|---|
| Authors: | Vernon SD; Bateman Horne Center, Salt Lake City, UT, United States., Rond C; Bateman Horne Center, Salt Lake City, UT, United States., Bell J; Bateman Horne Center, Salt Lake City, UT, United States., Butler B; Bateman Horne Center, Salt Lake City, UT, United States., Isolampi S; Bateman Horne Center, Salt Lake City, UT, United States., Otteson A; Bateman Horne Center, Salt Lake City, UT, United States., Phalwane P; Bateman Horne Center, Salt Lake City, UT, United States., Mower S; Department of Mechanical Engineering, University of Utah, Salt Lake City, UT, United States., Roundy S; Department of Mechanical Engineering, University of Utah, Salt Lake City, UT, United States., Kaufman DL; Center for Complex Diseases, Seattle, WA, United States., Cash AB; Terra Biological LLC, San Diego, CA, United States., Bateman L; Bateman Horne Center, Salt Lake City, UT, United States. |
| Source: | Frontiers in neuroscience [Front Neurosci] 2025 Jul 18; Vol. 19, pp. 1627462. Date of Electronic Publication: 2025 Jul 18 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101478481 Publication Model: eCollection Cited Medium: Print ISSN: 1662-4548 (Print) Linking ISSN: 1662453X NLM ISO Abbreviation: Front Neurosci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40757370 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: REGAIN: a randomized controlled clinical trial of oxaloacetate for improving the symptoms of long COVID. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Vernon+SD%22">Vernon SD</searchLink>; Bateman Horne Center, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Rond+C%22">Rond C</searchLink>; Bateman Horne Center, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Bell+J%22">Bell J</searchLink>; Bateman Horne Center, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Butler+B%22">Butler B</searchLink>; Bateman Horne Center, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Isolampi+S%22">Isolampi S</searchLink>; Bateman Horne Center, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Otteson+A%22">Otteson A</searchLink>; Bateman Horne Center, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Phalwane+P%22">Phalwane P</searchLink>; Bateman Horne Center, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Mower+S%22">Mower S</searchLink>; Department of Mechanical Engineering, University of Utah, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Roundy+S%22">Roundy S</searchLink>; Department of Mechanical Engineering, University of Utah, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Kaufman+DL%22">Kaufman DL</searchLink>; Center for Complex Diseases, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Cash+AB%22">Cash AB</searchLink>; Terra Biological LLC, San Diego, CA, United States.<br /><searchLink fieldCode="AU" term="%22Bateman+L%22">Bateman L</searchLink>; Bateman Horne Center, Salt Lake City, UT, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101478481%22">Frontiers in neuroscience</searchLink> [Front Neurosci] 2025 Jul 18; Vol. 19, pp. 1627462. <i>Date of Electronic Publication: </i>2025 Jul 18 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101478481 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1662-4548 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221662453X%22">1662453X </searchLink><i>NLM ISO Abbreviation: </i>Front Neurosci <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40757370 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fnins.2025.1627462 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1627462 Titles: – TitleFull: REGAIN: a randomized controlled clinical trial of oxaloacetate for improving the symptoms of long COVID. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Vernon SD – PersonEntity: Name: NameFull: Rond C – PersonEntity: Name: NameFull: Bell J – PersonEntity: Name: NameFull: Butler B – PersonEntity: Name: NameFull: Isolampi S – PersonEntity: Name: NameFull: Otteson A – PersonEntity: Name: NameFull: Phalwane P – PersonEntity: Name: NameFull: Mower S – PersonEntity: Name: NameFull: Roundy S – PersonEntity: Name: NameFull: Kaufman DL – PersonEntity: Name: NameFull: Cash AB – PersonEntity: Name: NameFull: Bateman L IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 07 Text: 2025 Jul 18 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 1662-4548 Numbering: – Type: volume Value: 19 Titles: – TitleFull: Frontiers in neuroscience Type: main |
| ResultId | 1 |